MMP9 and chronic obstructive pulmonary disease: The proportions of patients with the C‐1562T genotype in COPD‐NS and COPD‐S groups were within the same range (6% versus 12.6%, respectively), and the respective serum levels of MMP‐9 were similar (365.38 versus 352.03 ng/ml, respectively).